Novo Nordisk
Canadian Government Invests $75M More in Aspect Biosystems
Canadian bioprinting startup Aspect Biosystems has received a $72.75 million investment from Canada and the province of British Columbia. This supports earlier investments amounting to $200 million in Aspect’s technology…
Featured
Aspect Biosystems Strikes $2.6B Bioprinted Tissue Deal with Novo Nordisk
Bioprinting collaborations are heating up in 2023. In one of the biggest moves of the bioprinting industry, Canadian startup Aspect Biosystems and Danish pharma giant Novo Nordisk (CPH: NOVO-B) struck…
